(Q39704227)

14 September 2017

Anticlotting properties of fragments D from human fibrinogen and fibrin (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

30 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

30 April 2022

author name string

F. Haverkate

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A118016

30 April 2022

G. Timan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A118016

30 April 2022

W. Nieuwenhuizen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A118016

30 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=118016

30 April 2022

publication date

1 August 1979

1 reference

full work available at URL

14 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2362.1979.tb00881.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.1979.tb00881.x/fullpdf

30 April 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

European Journal of Clinical Investigation

30 April 2022

published in

1 reference

14 September 2017

9

1 reference

14 September 2017

4

1 reference

14 September 2017

253-255

1 reference

Fragments D - correlation between structure and biological activity

14 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB00881.X

Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB00881.X

Ca binding of rat fibrinogen and fibrin(ogen) degradation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB00881.X

Calcium-binding properties of human fibrin(ogen) and degradation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.1979.TB00881.X

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization

21 January 2018

3

41

917

Alkjaersig N.

1962

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

23 Rabbit plasminogen and plasmin isozymes

30 April 2022

10

45

273

Castellino F.J.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

Affinity chromatography of plasminogen

30 April 2022

11

24

424

Chibber B.A.K.

1974

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

American Journal of Physiology

30 April 2022

15

233

H305

Orloff K.G.

1977

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

Purification of rat fibrinogen and its constituent chains

30 April 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1979.TB00881.X

30 November 2022

Identifiers

1 reference

14 September 2017

1 reference